Antidote Therapeutics Progresses Optimization of the Nicotine-degrading Enzyme, NicA2, for Potential Use in Treating Nicotine Addiction – BioSpace

August 6, 2019 by  
Filed under The Smoker Stop News

Antidote Therapeutics Progresses Optimization of the Nicotine-degrading Enzyme, NicA2, for Potential Use in Treating Nicotine Addiction  BioSpace

GAITHERSBURG, Md.–(BUSINESS WIRE)– Antidote Therapeutics, Inc.(ATI) announced today the publication of the successful protein engineering of …

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*